“The clinical trial supplies market is expected to reach USD 1,274.3 million by 2020 from USD 904.3 million in 2015, at a CAGR of 7.1%. The global clinical trial supplies market is segmented based on products and services, phases, therapeutic areas, and regions. The logistics and distribution services segment is expected to register the highest growth rate in the clinical trial supplies market, by products and services, during the forecast period. The high growth in this segment is attributed to the globalization of clinical trials and increasing outsourcing services.
The major factors contributing to the growth of the clinical trial supplies market include globalization of clinical trial activities, increasing R&D investments and government support, and rising incidences of various diseases. Furthermore, increasing expansion activities by CROs is another major factor driving the growth of this market.
For instance, in October 2014, Almac expanded its U.K. commercial packaging facility with a significant investment to meet the requirement of Japanese clients. The expansion included an extensive suite of modifications for processing humidity-sensitive drug products; the installation of a new Noack 623 blister line; a custom designed desiccant feeder; and an off-line Hapa Blister-Jet printer. Increasing patent expiry and development of generic drugs and high growth potential in emerging markets has opened an array of opportunities for the clinical trial supplies market. However, factors such as longer approval times for clinical trials are hampering the growth of the market to a certain extent.
Apart from comprehensive geographic and product/service analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding service offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product/service portfolios of the top players in the clinical trial supplies market. The report analyzes the clinical trial supplies market by products and services, phases, therapeutic areas, and regions
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the clinical trial supplies market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the clinical trial supplies market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various clinical trial supplies market services and products across geographies
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the clinical trial supplies market
”
“TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 14
1.3.1 MARKET SEGMENTATION 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.3 MARKET SHARE ESTIMATION 22
2.3.1 KEY DATA FROM SECONDARY SOURCES 22
2.3.2 KEY DATA FROM PRIMARY SOURCES 23
2.3.3 KEY INDUSTRY INSIGHTS 23
2.4 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 30
4.1 CLINICAL TRIAL SUPPLIES MARKET 30
4.2 CLINICAL TRIAL SUPPLIES MARKET SHARE, SERVICES VS. REGIONS 31
4.3 GEOGRAPHIC ANALYSIS: CLINICAL TRIAL SUPPLIES MARKET, BY PHASE 32
4.4 GEOGRAPHIC ANALYSIS: CLINICAL TRIAL SUPPLIES MARKET, BY PRODUCT 33
4.5 LIFECYCLE ANALYSIS, BY REGION 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 CLINICAL TRIAL SUPPLIES: MARKET SEGMENTATION 36
5.2.1 BY PRODUCTS AND SERVICES 36
5.2.2 BY PHASE 36
5.2.3 BY THERAPEUTIC AREA 37
5.2.4 BY REGION 37
5.3 MARKET DYNAMICS 38
5.3.1 MARKET DRIVERS 38
5.3.1.1 Globalization of clinical trial activities 38
5.3.1.2 Increasing R&D investments and government support 38
5.3.1.3 Rising incidences of various diseases 39
5.3.1.4 Increasing expansion activities by CROs 39
5.3.2 MARKET RESTRAINS 40
5.3.2.1 Longer approval times for clinical trials 40
5.3.3 OPPORTUNITIES 41
5.3.3.1 Emerging markets 41
5.3.3.2 Increasing number of patent expirations and development of generic drugs 41
5.4 INDUSTRY TRENDS 42
5.4.1 JUST–IN-TIME PACKAGING AND LABELING METHODS FOR CLINICAL TRIAL SUPPLIES 42
6 CLINICAL TRIAL SUPPLIES MARKET, BY PRODUCT AND SERVICE 43
6.1 INTRODUCTION 44
6.2 MANUFACTURING 47
6.3 PACKAGING AND LABELING 50
6.4 LOGISTICS AND DISTRIBUTION 52
7 CLINICAL TRIAL SUPPLIES MARKET, BY PHASE 55
7.1 INTRODUCTION 56
7.2 PHASE I 58
7.3 PHASE II 59
7.4 PHASE III AND BIOEQUIVALENCE STUDIES 60
8 CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC AREA 62
8.1 INTRODUCTION 63
8.2 ONCOLOGY 65
8.3 CNS AND MENTAL DISORDERS 67
8.4 CARDIOVASCULAR DISEASES 68
8.5 INFECTIOUS DISEASES 69
8.6 RESPIRATORY DISEASES 70
8.7 BLOOD DISORDERS 71
8.8 DERMATOLOGY 72
8.9 OTHERS 73
9 CLINICAL TRIAL SUPPLIES MARKET, BY REGION 74
9.1 INTRODUCTION 75
9.2 NORTH AMERICA 76
9.2.1 U.S. 79
9.2.2 CANADA 81
9.3 EUROPE 83
9.3.1 U.K. 85
9.3.2 GERMANY 86
9.3.3 FRANCE 87
9.3.4 SPAIN 88
9.3.5 ITALY 89
9.3.6 REST OF EUROPE (ROE) 90
9.4 ASIA-PACIFIC 91
9.4.1 CHINA 94
9.4.2 INDIA 95
9.4.3 JAPAN 96
9.4.4 REST OF ASIA-PACIFIC (ROAPAC) 97
9.5 REST OF THE WORLD (ROW) 98
10 COMPETITIVE LANDSCAPE 101
10.1 OVERVIEW 101
10.2 MARKET SHARE ANALYSIS 102
10.3 COMPETITIVE SITUATIONS AND TRENDS 103
10.3.1 EXPANSION 104
10.3.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURE 104
10.3.3 ACQUISITIONS 105
10.3.4 NEW PRODUCT AND SERVICE LAUNCHES 106
10.3.5 OTHERS 107
11 COMPANY PROFILES 108
(Overview, Financials, Products & Services, and Developments)*
11.1 INTRODUCTION 108
11.2 ALMAC GROUP LTD, 109
11.3 CATALENT PHARMA SOLUTIONS, INC. 112
11.4 PAREXEL INTERNATIONAL 116
11.5 THERMO FISHER SCIENTIFIC, INC. 118
11.6 PCI SERVICES 120
11.7 PATHEON, INC. 122
11.8 SHARP PACKAGING SERVICES 123
11.9 BIOCAIR 125
11.10 MOVIANTO 126
11.11 KLIFO A/S. 127
*Details on overview, financials, product & services, and developments might not be captured in case of unlisted companies.
12 APPENDIX 128
12.1 INSIGHTS OF INDUSTRY EXPERTS 128
12.2 DISCUSSION GUIDE 129
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 132
12.4 AVAILABLE CUSTOMIZATIONS 132
12.5 RELATED REPORTS 133
“
“LIST OF TABLES
TABLE 1 INCREASING EXPANSION ACTIVITIES BY CROS TO BOOST THE MARKET GROWTH FOR CLINICAL TRIAL SUPPLIES 40
TABLE 2 LONGER APPROVAL TIMES FOR CLINICAL TRIALS ARE RESTRAINING THE GROWTH OF THE MARKET 40
TABLE 3 GROWTH PROSPECTS IN EMERGING COUNTRIES TO FUEL THE MARKET GROWTH 41
TABLE 4 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT AND SERVICE,
2013–2020 (USD MILLION) 44
TABLE 5 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 45
TABLE 6 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 45
TABLE 7 EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 46
TABLE 8 ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 46
TABLE 9 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR MANUFACTURING SERVICES,
BY REGION, 2013–2020 (USD MILLION) 48
TABLE 10 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR MANUFACTURING SERVICES, BY COUNTRY, 2013–2020 (USD MILLION) 48
TABLE 11 EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR MANUFACTURING SERVICES, BY COUNTRY, 2013–2020 (USD MILLION) 49
TABLE 12 ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR MANUFACTURING SERVICES, BY COUNTRY, 2013–2020 (USD MILLION) 49
TABLE 13 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PACKAGING AND LABELING SERVICES, BY REGION, 2013–2020 (USD MILLION) 50
TABLE 14 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PACKAGING AND LABELING SERVICES, BY COUNTRY, 2013–2020 (USD MILLION) 51
TABLE 15 EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PACKAGING AND LABELING SERVICES, BY COUNTRY, 2013–2020 (USD MILLION) 51
TABLE 16 ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PACKAGING AND LABELING SERVICES, BY COUNTRY, 2013–2020 (USD MILLION) 52
TABLE 17 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR LOGISTICS AND DISTRIBUTION SERVICES, BY REGION, 2013–2020 (USD MILLION) 53
TABLE 18 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR LOGISTICS AND DISTRIBUTION SERVICES, BY COUNTRY, 2013–2020 (USD MILLION) 53
TABLE 19 EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR LOGISTICS AND DISTRIBUTION SERVICES, BY COUNTRY, 2013–2020 (USD MILLION) 54
TABLE 20 ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR LOGISTICS AND DISTRIBUTION SERVICES, BY COUNTRY, 2013–2020 (USD MILLION) 54
TABLE 21 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2013–2020 (USD MILLION) 56
TABLE 22 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 57
TABLE 23 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY,
2013–2020 (USD MILLION) 57
TABLE 24 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE I TRIALS, BY REGION,
2013–2020 (USD MILLION) 58
TABLE 25 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE I TRIALS,
BY COUNTRY, 2013–2020 (USD MILLION) 58
TABLE 26 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE II TRIALS, BY REGION,
2013–2020 (USD MILLION) 59
TABLE 27 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE II TRIALS,
BY COUNTRY, 2013–2020 (USD MILLION) 60
TABLE 28 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE III TRIALS, BY REGION,
2013–2020 (USD MILLION) 60
TABLE 29 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE FOR PHASE III TRIALS,
BY COUNTRY, 2013–2020 (USD MILLION) 61
TABLE 30 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA,
2013–2020 (USD MILLION) 64
TABLE 31 CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 64
TABLE 32 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR ONCOLOGY, BY REGION,
2013–2020 (USD MILLION) 66
TABLE 33 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR CNS AND MENTAL DISORDERS,
BY REGION, 2013–2020 (USD MILLION) 67
TABLE 34 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR CARDIOVASCULAR DISEASES,
BY REGION, 2013–2020 (USD MILLION) 68
TABLE 35 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR INFECTIOUS DISEASES, BY REGION, 2013–2020 (USD MILLION) 69
TABLE 36 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR RESPIRATORY DISEASES, BY REGION, 2013–2020 (USD MILLION) 70
TABLE 37 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR BLOOD DISORDERS, BY REGION, 2013–2020 (USD MILLION) 71
TABLE 38 CLINICAL TRIAL SUPPLIES MARKET SIZE FOR DERMATOLOGY, BY REGION,
2013–2020 (USD MILLION) 72
TABLE 39 CLINICAL TRIAL SUPPLIES MARKET FOR OTHER APPLICATIONS, BY REGION,
2013–2020 (USD MILLION) 73
TABLE 40 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013–2020 (USD MILLION) 78
TABLE 41 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE,
2013–2020 (USD MILLION) 78
TABLE 42 NORTH AMERICA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2013–2020 (USD MILLION) 79
TABLE 43 U.S.: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 80
TABLE 44 U.S.: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE,
2013–2020 (USD MILLION) 81
TABLE 45 CANADA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013–2020 (USD MILLION) 82
TABLE 46 CANADA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE,
2013–2020 (USD MILLION) 82
TABLE 47 EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013–2020 (USD MILLION) 84
TABLE 48 EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE,
2013–2020 (USD MILLION) 84
TABLE 49 EUROPE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA,
2013–2020 (USD MILLION) 85
TABLE 50 U.K.: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 86
TABLE 51 GERMANY: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013–2020 (USD MILLION) 87
TABLE 52 FRANCE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013–2020 (USD MILLION) 88
TABLE 53 SPAIN: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 89
TABLE 54 ITALY: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 89
TABLE 55 ROE: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 90
TABLE 56 ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013–2020 (USD MILLION) 93
TABLE 57 ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE,
2013–2020 (USD MILLION) 93
TABLE 58 ASIA-PACIFIC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2013–2020 (USD MILLION) 94
TABLE 59 CHINA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 95
TABLE 60 INDIA: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 96
TABLE 61 JAPAN: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 97
TABLE 62 ROAPAC: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES, 2013–2020 (USD MILLION) 98
TABLE 63 ROW: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCTS & SERVICES,
2013–2020 (USD MILLION) 99
TABLE 64 ROW: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE,
2013–2020 (USD MILLION) 99
TABLE 65 ROW: CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA,
2013–2020 (USD MILLION) 100
TABLE 66 EXPANSIONS, 2012–2015 104
TABLE 67 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURE,
2012–2015 104
TABLE 68 ACQUISITIONS, 2012–2015 105
TABLE 69 NEW PRODUCT AND SERVICE LAUNCHES, 2012–2015 106
TABLE 70 OTHERS, 2012–2015 107
“
“LIST OF FIGURES
FIGURE 1 CLINICAL TRIAL SUPPLIES MARKET 15
FIGURE 2 RESEARCH DESIGN 17
FIGURE 3 TOP-DOWN APPROACH 19
FIGURE 4 BOTTOM-UP APPROACH 19
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
& REGION 20
FIGURE 6 DATA TRIANGULATION METHODOLOGY 21
FIGURE 7 CLINICAL TRIAL PRODUCTS AND SERVICES MARKET SNAPSHOT, 2015 VS. 2020 25
FIGURE 8 NORTH AMERICA TO DOMINATE THE LOGISTICS AND DISTRIBUTION MARKET FROM 2015 TO 2020 26
FIGURE 9 ONCOLOGY SEGMENT TO COMMAND THE LARGEST MARKET SHARE AND IS EXPECTED TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 26
FIGURE 10 PHASE III TO DOMINATE THE CLINICAL TRIAL SUPPLIES MARKET
FROM 2015 TO 2020 27
FIGURE 11 CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2015 28
FIGURE 12 ASIA-PACIFIC REGION TO WITNESS HIGHEST GROWTH RATE IN THE CLINICAL TRIAL SUPPLIES MARKET FROM 2015 TO 2020 29
FIGURE 13 CLINICAL TRIAL SUPPLIES MARKET TO SHOWCASE LUCRATIVE GROWTH OPPORTUNITIES IN THE FORECAST PERIOD 30
FIGURE 14 LOGISTICS AND DISTRIBUTION SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 31
FIGURE 15 PHASE III SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 32
FIGURE 16 LOGISTICS AND DISTRIBUTION WILL CONTINUE TO LEAD THE MARKET IN THE FORECAST PERIOD 33
FIGURE 17 ASIA-PACIFIC MARKET FOR CLINICAL TRIAL SUPPLIES TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 34
FIGURE 18 CLINICAL TRIAL SUPPLIES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 38
FIGURE 19 LOGISTICS AND DISTRIBUTION SERVICES SEGMENT EXPECTED TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 44
FIGURE 20 NORTH AMERICA EXPECTED TO DOMINATE THE MARKET FOR MANUFACTURING SERVICES IN THE FORECAST PERIOD 47
FIGURE 21 PHASE III SEGMENT IS EXPECTED TO DOMINATE THE MARKET IN THE FORECAST PERIOD 56
FIGURE 22 ONCOLOGY SEGMENT DOMINATES THE CLINICAL TRIAL SUPPLIES MARKET IN 2015 63
FIGURE 23 NORTH AMERICA DOMINATES THE ONCOLOGY MARKET IN 2015 66
FIGURE 24 GEOGRAPHIC SNAPSHOT: EMERGING MARKETS HOLD SIGNIFICANT GROWTH OPPORTUNITIES IN THE FORECAST PERIOD 75
FIGURE 25 NORTH AMERICA: MARKET SNAPSHOT 77
FIGURE 26 PHASE III SEGMENT WILL DRIVE THE GROWTH OF THE CLINICAL TRIAL SUPPLIES MARKET IN THE U.S. IN THE FORECAST PERIOD 80
FIGURE 27 GERMANY IS PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 83
FIGURE 28 ASIA-PACIFIC: MARKET SNAPSHOT 92
FIGURE 29 EXPANSION WAS THE MAJOR STRATEGY ADOPTED BETWEEN 2012 AND 2015 101
FIGURE 30 GLOBAL CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2014 102
FIGURE 31 BATTLE FOR MARKET SHARE: EXPANSION, THE MOST ACTIVELY ADOPTED STRATEGY BY MARKET PLAYERS 103
FIGURE 32 PRODUCT BENCHMARKING FOR MAJOR PLAYERS 108
FIGURE 33 CATALENT PHARMA SOLUTIONS, INC.: COMPANY SNAPSHOT 112
FIGURE 34 PAREXEL INTERNATIONAL: COMPANY SNAPSHOT 116
FIGURE 35 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 118
FIGURE 36 SHARP PACKAGING SERVICES: COMPANY SNAPSHOT 123
“
